# Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

> **NCT01195103** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 13 (actual)

## Conditions studied

- Procedural Sedation
- Regional Anesthesia Block
- Orthopedic Surgery

## Interventions

- **DRUG:** Fospropofol disodium
- **DRUG:** Fospropofol disodium
- **DRUG:** Placebo + Midazolam
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT01195103
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Funding terminated by funding source.
- **Last updated:** 2012-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01195103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01195103, "Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01195103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*